Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.

Chan, D; Binks, S; Nicholas, JM; Frost, C; Cardoso, MJ; Ourselin, S; Wilkie, D; Nicholas, R; Chataway, J; (2017) Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet neurology, 16 (8). pp. 591-600. ISSN 1474-4422 DOI: https://doi.org/10.1016/S1474-4422(17)30113-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1474-4422(17)30113-8

Abstract

Share

Download

Filename: Effect of high-dose simvastatin_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar